JP Patent

JP7728178B2 — （ｓ）－１－（４－フルオロフェニル）－１－（２－（４－（６－（１－メチル－１ｈ－ピラゾール－４－イル）ピロロ［２，１－ｆ］［１、２，４］トリアジン－４－イル）ピペラジニル）－ピリミジン－５－イル）エタン－１－アミンの結晶形態及び製造方法

Assigned to ブループリント メディシンズ コーポレイション · Expires 2025-08-22 · 1y expired

What this patent protects

Patent listed against Ayvakit.

Drugs covered by this patent

Patent Metadata

Patent number
JP7728178B2
Jurisdiction
JP
Classification
—
Expires
2025-08-22
Drug substance claim
No
Drug product claim
No
Assignee
ブループリント メディシンズ コーポレイション
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.